Tornier, N.V. TRNX, a global medical device company focused on
providing surgical solutions to orthopaedic extremity specialists,
announced today the pricing of a previously announced underwritten
registered public offering of 7.0 million ordinary shares at a public
offering price of $16.15 per ordinary share. The offering is expected to
close on or about May 15, 2013.
Of the 7.0 million ordinary shares being sold in the offering, 4.5
million shares are being sold by Tornier and 2.5 million shares are
being sold by certain existing shareholders. The selling shareholders
include funds associated with affiliates of Warburg Pincus LLC and The
Vertical Group, L.P. In addition, Tornier and the selling shareholders
have granted the underwriters a
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in